Detalhe da pesquisa
1.
Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes.
Br J Cancer
; 128(1): 91-101, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323879
2.
Economic impact of using risk models for eligibility selection to the International lung screening Trial.
Lung Cancer
; 176: 38-45, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592498
3.
Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods.
Lung Cancer
; 166: 122-131, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276628
4.
Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening.
Lung Cancer
; 169: 47-54, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643060